Mycobiome analyses of critically ill COVID-19 patients
ABSTRACT Coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) is a life-threatening complication in patients with severe COVID-19. Previously, acute respiratory distress syndrome in patients with COVID-19 has been associated with lung fungal dysbiosis, evidenced by reduced m...
Saved in:
Main Authors: | Danielle Weaver, Sara Gago, Matteo Bassetti, Daniele Roberto Giacobbe, Juergen Prattes, Martin Hoenigl, Florian Reizine, Hélène Guegan, Jean-Pierre Gangneux, Michael John Bromley, Paul Bowyer |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2025-02-01
|
Series: | Microbiology Spectrum |
Subjects: | |
Online Access: | https://journals.asm.org/doi/10.1128/spectrum.04110-23 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dysbiosis of the human skin mycobiome in patients receiving systemic IL-23 inhibitors
by: Yuta Koike, et al.
Published: (2025-01-01) -
The mycobiome in human cancer: analytical challenges, molecular mechanisms, and therapeutic implications
by: Ting Ding, et al.
Published: (2025-01-01) -
Gut mycobiome and neuropsychiatric disorders: insights and therapeutic potential
by: Ines Hadrich, et al.
Published: (2025-01-01) -
Gut mycobiome alterations and network interactions with the bacteriome in patients with atherosclerotic cardiovascular disease
by: Guangming Su, et al.
Published: (2025-01-01) -
Metagenomic and Transcriptomic Analysis Reveals Crosstalk Between Intratumor Mycobiome and Hosts in Early‐Stage Nonsmoking Lung Adenocarcinoma Patients
by: Yaohui Sun, et al.
Published: (2025-01-01)